ToolGen
Geumgok · Founded 1999
About ToolGen
ToolGen, a biotechnology company, focuses on the development of genome editing technology. Its products include gRNA/Cas9 purified that provides ready-to-use reagents for genome engineering experiments; gRNA/Cas9 plasmid that offers tools for genome editing experiment; and recombinant Cas9 protein that offers ready-to-use reagents for genome engineering experiments. ToolGen also offers genome-edited cell line; genome-edited mouse/rat; and genome-edited plant services, as well as surrogate reporter synthesis and in-del analysis services. Its products are used in research applications. ToolGen began operation in 1999, with its headquarters in Seoul in South Korea. ToolGen is a subsidiary of NSN.
Company Facts
- Founded: 1999
- Legal name: ToolGen Incorporated
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Last round: Corporate Round (Dec 2020)
- Website: toolgen.com
- Phone: 82 2 873 8168
Social Profiles
Canonical: https://fsome.com/organization/toolgen-8365612 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.